Assessment of cytotoxicity exerted by leaf extracts from plants of the genus Rhododendron towards epidermal keratinocytes and intestine epithelial cells

BMC Complementary and Alternative Medicine

Klaudia Brix¹  Matthias S. Ullrich¹  Hartwig Schepker²  Warren John¹  Alaa Al-Hashimi¹  Ahmed Rezk¹ 

[1] Department of Life Sciences and Chemistry, Jacobs University Bremen, Campus Ring 1, Bremen, D-28759, Germany;Stiftung Bremer Rhododendronpark, Deliusweg 40, Bremen, D-28359, Germany

关键词: Programmed cell death;    Mitochondrial activity;    Cytotoxicity;    Bio-active compounds;    Rhododendron;   

Others  :  1233247
DOI  :  10.1186/s12906-015-0860-8

 received in 2015-07-03, accepted in 2015-09-10,  发布年份 2015

【 摘 要 】

Background

Rhododendron leaf extracts were previously found to exert antimicrobial activities against a range of Gram-positive bacteria. In this study, we investigated which of the extracts with these antimicrobial properties would be best suited for further exploitation. Specifically, the project aims to identify biologically active compounds that affect bacterial but not mammalian cells when applied in medical treatments such as lotions for ectopic application onto skin, or as orally administered drugs.

Methods

Different concentrations of DMSO-dissolved remnants of crude methanol Rhododendron leaf extracts were incubated for 24 h with cultured epidermal keratinocytes (human HaCaT cell line) and epithelial cells of the intestinal mucosa (rat IEC6 cell line) and tested for their cytotoxic potential. In particular, the cytotoxic potencies of the compounds contained in antimicrobial Rhododendron leaf extracts were assessed by quantifying their effects on (i) plasma membrane integrity, (ii) cell viability and proliferation rates, (iii) cellular metabolism, (iv) cytoskeletal architecture, and (v) determining initiation of cell death pathways by morphological and biochemical means.

Results

Extracts of almost all Rhododendron species, when applied at 500 μg/mL, were potent in negatively affecting both keratinocytes and intestine epithelial cells, except material from R. hippophaeoides var. hippophaeoides. Extracts of R. minus and R. racemosum were non-toxic towards both mammalian cell types when used at 50 μg/mL, which was equivalent to their minimal inhibitory concentration against bacteria. At this concentration, leaf extracts from three other highly potent antimicrobial Rhododendron species proved non-cytotoxic against one or the other mammalian cell type: Extracts of R. ferrugineum were non-toxic towards IEC6 cells, and extracts of R. rubiginosum as well as R. concinnum did not affect HaCaT cells. In general, keratinocytes proved more resistant than intestine epithelial cells against the treatment with compounds contained in Rhododendron leaf extracts.

Conclusions

We conclude that leaf extracts from highly potent antimicrobial R. minus and R. racemosum are safe to use at 50 μg/mL in 24-h incubations with HaCaT keratinocytes and IEC6 intestine epithelial cells in monolayer cultures. Extracts from R. rubiginosum as well as R. concinnum or R. ferrugineum are applicable to either keratinocytes or intestinal epithelial cells, respectively. Beyond the scope of the current study, further experiments are required to identify the specific compounds contained in those Rhododendron leaf extracts that exert antimicrobial activity while being non-cytotoxic when applied onto human skin or gastrointestinal tract mucosa. Thus, this study supports the notion that detailed phytochemical profiling and compound identification is needed for characterization of the leaf extracts from specific Rhododendron species in order to exploit their components as supplementary agents in antimicrobial phyto-medical treatments.

【 授权许可】

   
2015 Rezk et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Fig. 6.

Fig. 7.

Fig. 8.

Fig. 9.

【 参考文献 】

• [1]Semkina OA. Ointments, gels, liniments, and creams containing phytopreparations (a review). Pharm Chem J. 2005; 39(7):369-74.
• [2]Fennell CW, Lindsey KL, McGaw LJ, Sparg SG, Stafford GI, Elgorashi EE, et al. Assessing African medicinal plants for efficacy and safety: pharmacological screening and toxicology. J Ethnopharmacol. 2004;94(2–3):205–17.
• [3]Solecki RS. Shanidar IV, a neanderthal flower burial in Northern Iraq. Science. 1975; 190(4217):880-1.
• [4]Zhang X. WHO traditional medicine strategy 2002–2005. World Health Organization, Geneva, Switzerland; 2002.
• [5]Farnsworth NR, D. Soejarto. Global importance of medicinal plants. The conservation of medicinal plants 1991:p. 25–51.
• [6]Kim H-S. Do not put too much value on conventional medicines. J Ethnopharmacol. 2005; 100(1–2):37-9.
• [7]Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005; 100(1–2):72-9.
• [8]Chicca A, Pellati F, Adinolfi B, Matthias A, Massarelli I, Benvenuti S, et al. Cytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallida. Br J Pharmacol. 2008;153(5):879–85.
• [9]De Silva T. Industrial utilization of medicinal plants in developing countries. Medicinal plants for forest conservation and health care FAO, Rome; 1997.
• [10]Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect. 2001; 109 Suppl 1:69-75.
• [11]Chichilnisky, G. Property rights on biodiversity and the pharmaceutical industry. Available at SSRN 1374617 1993.
• [12]King SR, Carlson TJ, Moran K. Biological diversity, indigenous knowledge, drug discovery and intellectual property rights: creating reciprocity and maintaining relationships. J Ethnopharmacol. 1996; 51(1–3):45-57.
• [13]Kartal M. Intellectual property protection in the natural product drug discovery, traditional herbal medicine and herbal medicinal products. Phytother Res. 2007; 21(2):113-9.
• [14]Cronquist A. The evolution and classification of flowering plants. Bronx, New York: New York Botanical Garden; 1968.
• [15]Palombo EA. Traditional medicinal plant extracts and natural products with activity against oral bacteria: potential application in the prevention and treatment of oral diseases. Evidence-Based Complementary and Alternative Medicine. 2011;2011:680354.
• [16]Yassin GH, Koek JH, Jayaraman S, Kuhnert N. Identification of novel homologous series of polyhydroxylated theasinensins and theanaphthoquinones in the SII fraction of black tea thearubigins using ESI/HPLC tandem mass spectrometry. J Agric Food Chem. 2014;62(40):9848–59.
• [17]Elliott M, Liu Y. The nine rights of medication administration: an overview. Br J Nurs. 2010; 19(5):300-5.
• [18]Tam TW, Liu R, Saleem A, Arnason JT, Krantis A, Haddad PS. The effect of Cree traditional medicinal teas on the activity of human cytochrome P450-mediated metabolism. J Ethnopharmacol. 2014;155(1):841–6.
• [19]Tiwari ON, Chauhan UK. Genus Rhododendron status in Sikkim Himalaya: an assessment. J Am Rhododendron Soc. 2005; 59:147-53.
• [20]Popescu R, Kopp B. The genus Rhododendron: an ethnopharmacological and toxicological review. J Ethnopharmacol. 2013; 147(1):42-62.
• [21]Shakeel-U-Rehman, Khan R, Bhat KA, Raja AF, Shawl AS, Alam MS. Isolation, characterisation and antibacterial activity studies of coumarins from Rhododendron lepidotum Wall. ex G. Don, Ericaceae. Revista Brasileira de Farmacognosia, 2010. 20:886–90.
• [22]Baral B, Vaidya GS, Maharjan BL, Da Silva JAT. Phytochemical and antimicrobial characterization of rhododendron anthopogon from high Nepalese Himalaya. Botanica Lithuanica. 2015;20(2):142–52.
• [23]Kupeli E, Tatli II, Akdemir ZS, Yesilada E. Bioassay-guided isolation of anti-inflammatory and antinociceptive glycoterpenoids from the flowers of Verbascum lasianthum Boiss. ex Bentham. J Ethnopharmacol. 2007;110(3):444–50.
• [24]Nisar M, Ali S, Muhammed N, Gillani SN, Shah MR, Khan H, et al. Antinociceptive and anti-inflammatory potential of Rhododendron arboreum bark. Toxicol Ind Health. 2014. Epub ahead of print.
• [25]Rezk A, Nolzen J, Schepker H, Albach DC, Brix K, Ullrich MS. Phylogenetic spectrum and analysis of antibacterial activities of leaf extracts from plants of the genus Rhododendron. BMC Complement Altern Med. 2015;15(1):1–10.
• [26]Seephonkai P, Popescu R, Zehl M, Krupitza G, Urban E, Kopp B. Ferruginenes a − C from Rhododendron ferrugineum and their cytotoxic evaluation. J Nat Prod. 2011;74(4):712–7.
• [27]Li X, Jin H, Chen G, Yan S, Shen Y, Yang M, et al. Study advances on chemical constituents and pharmacological activities of the Tibetan medicine Dali. Nat Product Res & Development. 2008;20(6):1125–8.
• [28]Niles AL, Moravec RA, Riss TL. In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening. Current Chemical Genomics. 2009; 3:33-41.
• [29]Thomas C, Oates PS. IEC-6 cells are an appropriate model of intestinal iron absorption in rats. J Nutr. 2002; 132(4):680-7.
• [30]Mayer K, Vreeman A, Qu H, Brix K. Release of endo-lysosomal cathepsins B, D, and L from IEC6 cells in a cell culture model mimicking intestinal manipulation. Biol Chem. 2009;390(5/6):471–80.
• [31]Buth H, Luigi Buttigieg P, Ostafe R, Rehders M, Dannenmann SR, Schaschke N, et al. Cathepsin B is essential for regeneration of scratch-wounded normal human epidermal keratinocytes. Eur J Cell Biol. 2007;86(11–12):747–61.
• [32]Rehders M, Grosshäuser BB, Smarandache A, Sadhukhan A, Mirastschijski U, Kempf J, et al. Effects of lunar and mars dust simulants on HaCaT keratinocytes and CHO-K1 fibroblasts. Adv Space Res. 2011;47(7):1200–13.
• [33]Huet O, Petit JM, Ratinaud MH, Julien R. NADH-dependent dehydrogenase activity estimation by flow cytometric analysis of 3-(4,5-dimethylthiazolyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. Cytometry. 1992;13(5):532–9.
• [34]Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1–2):55-63.
• [35]Twentyman PR, Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer. 1987; 56(3):279-85.
• [36]Arampatzidou M, Rehders M, Dauth S, Yu DM, Tedelind S, Brix K. Imaging of protease functions-current guide to spotting cysteine cathepsins in classical and novel scenes of action in mammalian epithelial cells and tissues. Ital J Anat Embryol. 2011;116(1):1–19.
• [37]Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956; 62(2):315-23.
• [38]Cockerill FR, Wikler MA, Adler J, Dudley MN, Eliopoulos GM, Ferraro MJ, et al. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow Aerobically. Approved Standard - Ninth Edition. CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standard Institute. 2012.
• [39]Carpenter A, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O. Cell Profiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7(10):R100.
• [40]Iwata N, Wang N, Yao X, Kitanaka S. Structures and histamine release inhibitory effects of prenylated orcinol derivatives from rhododendron dauricum1. J Nat Prod. 2004;67(7):1106–9.
• [41]Bhattacharyya D. Rhododendron species and their uses with special reference to Himalayas– a review. Assam University J Sci & Technology: Biological and Environ Sci. 2011; 7(1):161-7.
• [42]Peng YY, Liu FH, Ye JN. Determination of bioactive flavonoids in Rhododendron dauricum L. By capillary electrophoresis with electrochemical detection. Chromatographia. 2004; 60(9–10):597-602.
• [43]Cao Y, Chu Q, Ye J. Chromatographic and electrophoretic methods for pharmaceutically active compounds in Rhododendron dauricum. J Chromatogr B. 2004; 812(1–2):231-40.
• [44]Zou H-Y, Luo J, Xu DR, Kong LY. Tandem Solid-Phase Extraction Followed by HPLC–ESI/QTOF/MS/MS for Rapid Screening and Structural Identification of Trace Diterpenoids in Flowers of Rhododendron molle. Phytochem Anal. 2014;25(3):255–65.
• [45]Qiang Y, Zhou B, Gao K. Chemical constituents of plants from the genus Rhododendron. Chem Biodivers. 2011; 8(5):792-815.
• [46]Amil-Ruiz F, Bianco-Portales R, Muñoz-Blanco J, Caballero JL. The strawberry plant defense mechanism: a molecular review. Plant Cell Physiol. 2011;52(11):1873–903.
• [47]Jaiswal R, Jayasinghe L, Kuhnert N. Identification and characterization of proanthocyanidins of 16 members of the Rhododendron genus (Ericaceae) by tandem LC–MS. J Mass Spectrom. 2012; 47(4):502-15.
• [48]Santos FV, Colus IM, Silva MA, Vilegas W, Varanda EA. Assessment of DNA damage by extracts and fractions of Strychnos pseudoquina, a Brazilian medicinal plant with antiulcerogenic activity. Food Chem Toxicol. 2006;44(9):1585–9.
• [49]Mei N, Heflich RH, Chou MW, Chen T. Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelliine in the liver cII gene of transgenic Big blue rats. Chem Res Toxicol. 2004;17(6):814–8.
• [50]Farias Vargas Junior S, Marcolongo-Pereira C, Halinski-Silveira D, Grecco FB, Raffi MB, Schild AL, et al. Rhododendron simsii poisoning in goats in Southern Brazil. Ciência Rural. 2014;44(7):1249–52.
• [51]Puschner B, Holstege DM, Lamberski N. Grayanotoxin poisoning in three goats. J Am Vet Med Assoc. 2001;218(4):573–5. 527–78.
• [52]Berny P, Caloni F, Croubels S, Sachana M, Vandenbroucke V, Davanzo F, et al. Animal poisoning in Europe. Part 2: companion animals. Vet J. 2010;183(3):255–9.
• [53]Ernst E. Systematic reviews of herbal medicines. Am J Med. 2004; 117(7):533.
• [54]Rietjens IMCM, Boersma MG, van der Woude H, Jeurissen SMF, Schutte ME, Alink GM. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. Mutation research/fundamental and molecular mechanisms of mutagenesis. Genes and Environment Bridging the Gap. 2005;574(1–2):124–38.
• [55]Li FR, Yu FX, Yao ST, Si YH, Zhang W, Gao LL. Hyperin extracted from Manchurian rhododendron leaf induces apoptosis in human endometrial cancer cells through a mitochondrial pathway. Asian Pac J Cancer Prev. 2012;13(8):3653–6.
• [56]Way TD, Tsai SJ, Wang CM, Ho CT, Chou CH. Chemical constituents of Rhododendron formosanum show pronounced growth inhibitory effect on non-small-cell lung carcinoma cells. J Agric Food Chem. 2014;62(4):875–84.
• [57]Eckert RL, Rorke EA. Molecular biology of keratinocyte differentiation. Environ Health Perspect. 1989; 80(1):109-16.
• [58]Yuan J, Kroemer G. Alternative cell death mechanisms in development and beyond. Genes Dev. 2010; 24(23):2592-602.